Teva Pharmaceutical Industries (TEVA) Acquisitions (2010 - 2024)

Teva Pharmaceutical Industries (TEVA) posted Acquisitions of $15.0 million for Q1 2024, up 114.29% on a QoQ basis from $7.0 million in Q1 2022.

Teva Pharmaceutical Industries (TEVA) Acquisitions (2010 - 2024) Analysis & Trends

Teva Pharmaceutical Industries' Acquisitions history runs 2 years deep, the most recent figure standing at $15.0 million for Q1 2024.

Quarterly Acquisitions changed N/A year-over-year to $15.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $15.0 million (changed N/A YoY) and the FY2024 annual result came in at $15.0 million, changed N/A from the prior year.
Acquisitions was $15.0 million for Q1 2024 at Teva Pharmaceutical Industries, up from $7.0 million in the prior quarter.
Across five years, Acquisitions topped out at $15.0 million in Q1 2024 and bottomed at $7.0 million in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Vireo Growth	10.57 Bn	10.41 Bn	59.30 Mn	-18.20 Mn

Download Data